Clinical Stage Product Applications Available In Tuvalu

1 applications found

Microbiome Therapeutics for Clinical Trials

Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. ...

ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you